Devices › Introducer, catheter
Device brand name · Introducer catheter
Glidesheath Slender: medical device reports filed with FDA
625 reports name it, 2014–2026. Manufacturer given most often on reports: Terumo Medical. Product code DYB.
- 625
- device reports naming the brand
- 0% of all MAUDE reports · about 51 a year
- 95
- reports, 12 months to August 2026
- 31 in the 12 months before
- 84.3%
- classified as malfunction
- 64.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 625 reports that name the brand "Glidesheath Slender" (introducer catheter), received between May 2014 and August 2026; the manufacturer given most often on reports is Terumo Medical. Spellings of one product vary from report to report.
95 reports arrived in the 12 months to August 2026, up 206% from 31 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (84.3%), injury (15.4%) and other (0.2%); across all introducer, catheter reports (product code DYB) death is recorded in 3.3% and malfunction in 64.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are leak/splash (26.7%), product quality problem (13.4%) and material deformation (11.8%). The patient problems coded most often are blood loss, foreign body in patient and hematoma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 41,190 reports carrying product code DYB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Leak/splashthe device leaked | 167 | 26.7% | 4.4% |
| Product quality problem | 84 | 13.4% | 0.3% |
| Material deformation | 74 | 11.8% | 3.3% |
| Difficult to insertthe device was hard to insert | 52 | 8.3% | 3.1% |
| Difficult to advance | 46 | 7.4% | 1.9% |
| Breakthe device broke | 44 | 7% | 7.5% |
| Material separation | 20 | 3.2% | 12.3% |
| Failure to advance | 17 | 2.7% | 1.7% |
| Fracturea broken bone | 17 | 2.7% | 1.5% |
| Physical resistance/sticking | 16 | 2.6% | 2.1% |
| Detachment of device or device componentpart of the device came off | 9 | 1.4% | 4.5% |
| Fluid/blood leak | 9 | 1.4% | 10.7% |
| Peeled/delaminated | 8 | 1.3% | 1.4% |
| Material frayed | 6 | 1% | 1.2% |
| Activation, positioning or separation problem | 5 | 0.8% | 0.4% |
| Difficult to removethe device was hard to remove | 5 | 0.8% | 2.9% |
| Insufficient device problem information | 5 | 0.8% | 1.6% |
| Material twisted/bent | 5 | 0.8% | 0.8% |
| Separation problem | 5 | 0.8% | 0.2% |
| Unraveled material | 5 | 0.8% | 1.7% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Blood loss | 92 | 14.7% |
| Foreign body in patientpart of a device left in the patient | 26 | 4.2% |
| Hematomaa collection of blood under the skin or in tissue | 13 | 2.1% |
| Bruise/contusion | 4 | 0.6% |
| Hemorrhage/blood loss/bleeding | 4 | 0.6% |
| No patient involvement | 4 | 0.6% |
| Painpain, site not specified | 4 | 0.6% |
| Device embedded in tissue or plaque | 3 | 0.5% |
| Pseudoaneurysm | 3 | 0.5% |
| Obstruction/occlusion | 2 | 0.3% |
| Vascular dissection | 2 | 0.3% |
| Ventricular fibrillationa chaotic rhythm from the lower heart chambers | 2 | 0.3% |
| Cramp(s) /muscle spasm(s) | 1 | 0.2% |
| Discomfortdiscomfort | 1 | 0.2% |
| Dyskinesiainvoluntary movements | 1 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Glidesheath Slender | Product code DYB | All MAUDE reports |
|---|---|---|---|
| Reports | 625 | 41,190 | 26,136,888 |
| Share of that pool | — | 1.5% | 0% |
| Classified as death, per 1,000 reports | 0 | 33 | 9 |
| Classified as injury | 15.4% | 31.2% | 36.2% |
| Classified as malfunction | 84.3% | 64.6% | 62.3% |
| Filed by the manufacturer | 93.6% | 93.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DYB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Vizigo | 1,560 | 873 | 0.4% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath Medium | 1,381 | 0 | 0.1% |
| Micra | 7,144 | 524 | 8.4% |
| GORE DrySeal Flex Introducer Sheath | 1,177 | 283 | 5.3% |
| Edwards eSheath+ Introducer Set | 974 | 393 | 3.1% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath - Medium | 885 | 19 | 0.2% |
| Swartz Braided Transseptal Guiding Introducer, SL0, 63 cm Length, 8.5 F | 878 | 212 | 1.5% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath Small | 870 | 0 | 0% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath - Small | 707 | 11 | 0% |
| Flexor Ansel Guiding Sheath | 575 | 26 | 0.5% |
| Edwards eSheath Introducer Set | 1,393 | 15 | 9.7% |
| Flexor Raabe Guiding Sheath | 539 | 30 | 1.1% |
| Fast-Cath Transseptal Guiding Introducer Swartz SL Transseptal Series, SL1 8. | 505 | 26 | 0.8% |
| Edwards Transfemoral Esheath Unknown | 504 | 9 | 44.6% |
| Swartz Braided Transseptal Introducer, SL0, 8.5 F | 479 | 98 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Glidesheath Slender reports
How many FDA reports name Glidesheath Slender?
625 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 95 in the latest 12 months.
What kinds of events are reported?
malfunction (84.3%), injury (15.4%) and other (0.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
leak/splash (26.7%), product quality problem (13.4%), material deformation (11.8%), difficult to insert (8.3%) and difficult to advance (7.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (93.6%) and voluntary reports (0.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Glidesheath Slender was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.